Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

NYSEARCA:ELA - NYSE Arca - US29402E1029 - Common Stock - Currency: USD

5.63  -0.01 (-0.18%)

Fundamental Rating

7

ELA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 120 industry peers in the Specialty Retail industry. Both the health and profitability get an excellent rating, making ELA a very profitable company, without any liquidiy or solvency issues. ELA is growing strongly while it is still valued neutral. This is a good combination! These ratings would make ELA suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

ELA had positive earnings in the past year.
ELA had a positive operating cash flow in the past year.
Each year in the past 5 years ELA has been profitable.
In the past 5 years ELA always reported a positive cash flow from operatings.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

The Return On Assets of ELA (9.22%) is better than 80.83% of its industry peers.
Looking at the Return On Equity, with a value of 13.32%, ELA is in the better half of the industry, outperforming 69.17% of the companies in the same industry.
With a decent Return On Invested Capital value of 10.31%, ELA is doing good in the industry, outperforming 72.50% of the companies in the same industry.
ELA had an Average Return On Invested Capital over the past 3 years of 12.62%. This is in line with the industry average of 13.34%.
Industry RankSector Rank
ROA 9.22%
ROE 13.32%
ROIC 10.31%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

ELA's Profit Margin of 3.89% is fine compared to the rest of the industry. ELA outperforms 71.67% of its industry peers.
ELA's Profit Margin has improved in the last couple of years.
The Operating Margin of ELA (4.73%) is better than 65.83% of its industry peers.
In the last couple of years the Operating Margin of ELA has grown nicely.
ELA's Gross Margin of 24.35% is on the low side compared to the rest of the industry. ELA is outperformed by 75.00% of its industry peers.
ELA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.73%
PM (TTM) 3.89%
GM 24.35%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ELA is still creating some value.
ELA has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ELA has less shares outstanding
ELA has a better debt/assets ratio than last year.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ELA has an Altman-Z score of 7.29. This indicates that ELA is financially healthy and has little risk of bankruptcy at the moment.
ELA's Altman-Z score of 7.29 is amongst the best of the industry. ELA outperforms 95.00% of its industry peers.
ELA has a debt to FCF ratio of 3.28. This is a good value and a sign of high solvency as ELA would need 3.28 years to pay back of all of its debts.
ELA has a better Debt to FCF ratio (3.28) than 71.67% of its industry peers.
A Debt/Equity ratio of 0.18 indicates that ELA is not too dependend on debt financing.
The Debt to Equity ratio of ELA (0.18) is better than 63.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.28
Altman-Z 7.29
ROIC/WACC1.08
WACC9.57%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

A Current Ratio of 4.51 indicates that ELA has no problem at all paying its short term obligations.
The Current ratio of ELA (4.51) is better than 98.33% of its industry peers.
A Quick Ratio of 2.31 indicates that ELA has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.31, ELA belongs to the top of the industry, outperforming 93.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 2.31
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 16.67% over the past year.
ELA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.12% yearly.
Looking at the last year, ELA shows a quite strong growth in Revenue. The Revenue has grown by 15.71% in the last year.
The Revenue has been growing by 17.07% on average over the past years. This is quite good.
EPS 1Y (TTM)16.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%42.86%
Revenue 1Y (TTM)15.71%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.07%

3.2 Future

ELA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.39% yearly.
Based on estimates for the next years, ELA will show a quite strong growth in Revenue. The Revenue will grow by 8.74% on average per year.
EPS Next Y29.28%
EPS Next 2Y24.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.28%
Revenue Next 2Y8.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 20.11, which indicates a rather expensive current valuation of ELA.
66.67% of the companies in the same industry are more expensive than ELA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of ELA to the average of the S&P500 Index (26.52), we can say ELA is valued slightly cheaper.
The Price/Forward Earnings ratio is 14.55, which indicates a correct valuation of ELA.
66.67% of the companies in the same industry are more expensive than ELA, based on the Price/Forward Earnings ratio.
ELA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.25.
Industry RankSector Rank
PE 20.11
Fwd PE 14.55
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ELA.
The rest of the industry has a similar Price/Free Cash Flow ratio as ELA.
Industry RankSector Rank
P/FCF 36.34
EV/EBITDA 13.11
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ELA's earnings are expected to grow with 24.39% in the coming years.
PEG (NY)0.69
PEG (5Y)1
EPS Next 2Y24.39%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ELA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVELA CORP

NYSEARCA:ELA (6/6/2025, 8:04:00 PM)

5.63

-0.01 (-0.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/dmh
Earnings (Next)08-05 2025-08-05/amc
Inst Owners12.96%
Inst Owner Change5.35%
Ins Owners50.07%
Ins Owner Change0.05%
Market Cap146.38M
Analysts80
Price Target8.16 (44.94%)
Short Float %1.54%
Short Ratio4.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.13%
Min EPS beat(2)18.81%
Max EPS beat(2)41.44%
EPS beat(4)4
Avg EPS beat(4)31.9%
Min EPS beat(4)18.81%
Max EPS beat(4)48.51%
EPS beat(8)5
Avg EPS beat(8)9.86%
EPS beat(12)8
Avg EPS beat(12)25.22%
EPS beat(16)12
Avg EPS beat(16)26.31%
Revenue beat(2)2
Avg Revenue beat(2)9.94%
Min Revenue beat(2)2.14%
Max Revenue beat(2)17.74%
Revenue beat(4)4
Avg Revenue beat(4)15.97%
Min Revenue beat(4)2.14%
Max Revenue beat(4)22.84%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)4.74%
Revenue beat(16)12
Avg Revenue beat(16)7.62%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-23.53%
EPS NQ rev (3m)-35%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.86%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)3.34%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)4.68%
Valuation
Industry RankSector Rank
PE 20.11
Fwd PE 14.55
P/S 0.78
P/FCF 36.34
P/OCF 19.44
P/B 2.65
P/tB 3.07
EV/EBITDA 13.11
EPS(TTM)0.28
EY4.97%
EPS(NY)0.39
Fwd EY6.87%
FCF(TTM)0.15
FCFY2.75%
OCF(TTM)0.29
OCFY5.14%
SpS7.26
BVpS2.12
TBVpS1.83
PEG (NY)0.69
PEG (5Y)1
Profitability
Industry RankSector Rank
ROA 9.22%
ROE 13.32%
ROCE 13.18%
ROIC 10.31%
ROICexc 14.95%
ROICexgc 17.82%
OM 4.73%
PM (TTM) 3.89%
GM 24.35%
FCFM 2.13%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexcg growth 3Y-9.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.28
Debt/EBITDA 0.93
Cap/Depr 211.79%
Cap/Sales 1.86%
Interest Coverage 23.43
Cash Conversion 71.1%
Profit Quality 54.86%
Current Ratio 4.51
Quick Ratio 2.31
Altman-Z 7.29
F-Score7
WACC9.57%
ROIC/WACC1.08
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%42.86%
EPS Next Y29.28%
EPS Next 2Y24.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.71%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.07%
Revenue Next Year11.28%
Revenue Next 2Y8.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.46%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year58.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.44%
OCF growth 3Y53.73%
OCF growth 5YN/A